FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37690033> ?p ?o ?g. }

• Q37690033 description "article científic" @default.
• Q37690033 description "article scientifique" @default.
• Q37690033 description "articolo scientifico" @default.
• Q37690033 description "artigo científico" @default.
• Q37690033 description "artículu científicu espublizáu en 2017" @default.
• Q37690033 description "bilimsel makale" @default.
• Q37690033 description "scientific article published on 09 March 2017" @default.
• Q37690033 description "vedecký článok" @default.
• Q37690033 description "vetenskaplig artikel" @default.
• Q37690033 description "videnskabelig artikel" @default.
• Q37690033 description "vědecký článek" @default.
• Q37690033 description "wetenschappelijk artikel" @default.
• Q37690033 description "wissenschaftlicher Artikel" @default.
• Q37690033 description "наукова стаття, опублікована в березні 2017" @default.
• Q37690033 description "научни чланак" @default.
• Q37690033 description "مقالة علمية نشرت في 09 مارس 2017" @default.
• Q37690033 name "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 name "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 name "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 type Item @default.
• Q37690033 label "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 label "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 label "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 prefLabel "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 prefLabel "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 prefLabel "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis." @default.
• Q37690033 P1433 Q37690033-07C55DE6-40CE-4BC5-8513-181B11974503 @default.
• Q37690033 P1476 Q37690033-A7D6B27F-C870-47DD-8A02-CF3C83835C73 @default.
• Q37690033 P2093 Q37690033-1480A6E7-9358-4E80-BF23-0291984AFC5E @default.
• Q37690033 P2093 Q37690033-23BE5E3B-748F-481F-AECC-B0C7761A501A @default.
• Q37690033 P2093 Q37690033-5D370003-F4A6-4989-BE96-EEC06D442CB5 @default.
• Q37690033 P2093 Q37690033-5E9A2453-1FC1-4511-AB4C-7C8B59771E4F @default.
• Q37690033 P2093 Q37690033-7DD7C393-C71D-4926-9C6F-A602923E5C11 @default.
• Q37690033 P2093 Q37690033-9D113E0D-6100-4934-9106-47378FD6D3C3 @default.
• Q37690033 P2093 Q37690033-9EAB194A-999C-4E7C-A241-C7F58D6B4F21 @default.
• Q37690033 P2860 Q37690033-0894973D-6FD0-45EC-910F-D441FF5618DB @default.
• Q37690033 P2860 Q37690033-1345B072-563A-4E5D-9A87-FAC40F5255CB @default.
• Q37690033 P2860 Q37690033-30237C69-2641-4A2F-A19C-88675A1FC6C1 @default.
• Q37690033 P2860 Q37690033-343593C6-3854-468A-8B54-379394798D30 @default.
• Q37690033 P2860 Q37690033-3C304AAB-99EF-4931-9195-11E3A769803E @default.
• Q37690033 P2860 Q37690033-40E494D3-4B3A-4FED-9D01-726A0D1CF186 @default.
• Q37690033 P2860 Q37690033-41E244B3-5400-4185-BEC0-4D847B947474 @default.
• Q37690033 P2860 Q37690033-42E65429-58F4-472C-8CC3-326F43A94E9E @default.
• Q37690033 P2860 Q37690033-43547337-6233-4165-B748-E4EA6C6AD8E9 @default.
• Q37690033 P2860 Q37690033-51BA5DDD-1915-40FE-9332-54F3257DD329 @default.
• Q37690033 P2860 Q37690033-51CADBD0-9ECD-42E9-BB23-41F8FBEFB282 @default.
• Q37690033 P2860 Q37690033-5B5B8D61-A477-4F8A-9A23-10039B31E8D4 @default.
• Q37690033 P2860 Q37690033-6019024F-2713-4F21-8B52-56289A3D6ABE @default.
• Q37690033 P2860 Q37690033-610F5A3B-3448-4E6F-89C4-534567F6668B @default.
• Q37690033 P2860 Q37690033-61C3048E-BA18-408A-962A-0EB095559E83 @default.
• Q37690033 P2860 Q37690033-6337EFBA-AF8D-4E28-A360-45831A038154 @default.
• Q37690033 P2860 Q37690033-6F6FCFEF-BF21-41C9-BE62-551783AA68AB @default.
• Q37690033 P2860 Q37690033-718602CA-48E5-4CF4-AF5D-E1ACAA1A72C1 @default.
• Q37690033 P2860 Q37690033-7763D5B7-E576-4C1C-B15B-36C27295C554 @default.
• Q37690033 P2860 Q37690033-7CD3A9F2-307E-4E91-8298-F0AAD620BD08 @default.
• Q37690033 P2860 Q37690033-8350C3A1-E6FF-4078-A189-A01162884F4D @default.
• Q37690033 P2860 Q37690033-84E87679-C8DD-4313-BEE8-95B9BF77CB1A @default.
• Q37690033 P2860 Q37690033-8A2F54FA-23F6-4EF9-9B05-4D88D363F626 @default.
• Q37690033 P2860 Q37690033-8C7C875B-5EF3-43A3-9A2D-569F7534819D @default.
• Q37690033 P2860 Q37690033-9043584A-0F29-49F2-85A0-A07AA453B51C @default.
• Q37690033 P2860 Q37690033-983CCD34-8988-4021-AB5A-23B3CCF64F4B @default.
• Q37690033 P2860 Q37690033-9898FFD9-CB01-40AD-9F78-A76910FB5216 @default.
• Q37690033 P2860 Q37690033-99C29423-5BB1-40F6-9440-E1C28992EB6D @default.
• Q37690033 P2860 Q37690033-9D974DE0-F464-4589-8FA3-9BEBE54D1217 @default.
• Q37690033 P2860 Q37690033-A54FD8C3-C5CF-43AD-96AA-A60149BFD8E8 @default.
• Q37690033 P2860 Q37690033-BAE4C492-E515-4E25-ABF1-3A9873D849FB @default.
• Q37690033 P2860 Q37690033-D5B21D97-4C26-41C4-837A-C7D415ACAA44 @default.
• Q37690033 P2860 Q37690033-E5A56605-4F02-4A6B-9BB6-069319D78DE3 @default.
• Q37690033 P2860 Q37690033-E8B5C5F1-5962-418E-81A3-552D757AF89F @default.
• Q37690033 P2860 Q37690033-F4CC6E98-23C9-4538-B861-08E6D1EB3FBB @default.
• Q37690033 P2860 Q37690033-F54C86AC-E8C1-43A7-9F63-1F5DAB821225 @default.
• Q37690033 P2860 Q37690033-F8390D5B-7228-4255-863C-2A5C3BCF95DC @default.
• Q37690033 P2860 Q37690033-FCD5A40C-BBA1-412B-A5C1-D332475FDA75 @default.
• Q37690033 P2888 Q37690033-9AC8D153-BBDC-4FFD-92C6-43BD9F8C2E7E @default.
• Q37690033 P304 Q37690033-239B18D8-3E03-47CC-ADA7-25564DFDF411 @default.
• Q37690033 P31 Q37690033-C0099D76-D7AD-4394-9451-522A45A4ADCE @default.
• Q37690033 P356 Q37690033-B76DA435-6391-4CD8-8A1E-F47C9D78B49E @default.
• Q37690033 P433 Q37690033-AE0AA6EE-1621-491E-842E-B8DFAA92F069 @default.
• Q37690033 P478 Q37690033-FF97AB7F-B01F-4009-AFF7-33F0F8D7D687 @default.
• Q37690033 P50 Q37690033-8D903047-5C4C-414F-890B-5CFBD16847E7 @default.
• Q37690033 P577 Q37690033-C687C78A-47A0-44B6-AFA2-F95AE9126798 @default.
• Q37690033 P6179 Q37690033-23135C51-547F-44EB-B2BB-A906552C3D41 @default.
• Q37690033 P698 Q37690033-E191E868-F607-4313-A15B-A215DC4475B8 @default.
• Q37690033 P921 Q37690033-77922F1A-D54B-4714-8A67-00B745FB607A @default.
• Q37690033 P921 Q37690033-829C6E9D-3338-44D0-82E5-1A12522554C0 @default.
• Q37690033 P921 Q37690033-D7169A61-5394-435C-87AE-00D0DF25A356 @default.
• Q37690033 P932 Q37690033-4C3C3856-3EDE-4B74-A28B-50C1B8F54606 @default.
• Q37690033 P356 S13075-017-1267-3 @default.
• Q37690033 P698 28274253 @default.
• Q37690033 P1433 Q15757229 @default.
• Q37690033 P1476 "Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis" @default.
• Q37690033 P2093 "B Souberbielle" @default.
• Q37690033 P2093 "D Saurigny" @default.
• Q37690033 P2093 "E Esfandiari" @default.
• Q37690033 P2093 "E Lloyd" @default.
• Q37690033 P2093 "R Stoilov" @default.
• Q37690033 P2093 "T W J Huizinga" @default.
• Q37690033 P2093 "T Wagner" @default.
• Q37690033 P2860 Q24799657 @default.
• Q37690033 P2860 Q28601432 @default.

• next